Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Study of the Acceptability and Psychosocial Impact of Using a Telepresence Robot in the Living Space of Inpatients

NCT04899830 · Association APPROCHE · Updated 6 March 2026

What is being tested
Telepresence robot
For
Motor Disorders; Cognitive Disability
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 49 people. The full rules are on the registry page.
Where
France (4 sites)
When
Starts or started 24 Oct 2020, ends 18 April 2024. Registered 25 May 2021.
Results
None posted yet.

In the researchers' words

This study focuses on the mobile robot assist device for tele-interaction: the "COVEALINK 2" robot. This telepresence robot is designed for remote use inside the home. It works with an Internet connection (Wifi or 4G). It consists of a control interface (an application installed on the smartphone or tablet of the hospitalized patient) and a mobile robot placed in the home of the hospitalized patient (composed of a mobile platform, a visualization screen whose tilt is adjustable remotely for better adaptation to the interlocutors and an audio communication system). From the app installed on his smartphone or tablet, the patient hospitalized in the center for a long time (2 months minimum) will be able to start remotely (from the center where he is hospitalized) the robot and have it move within his home to communicate with the people present at the time of use (family, friends, neighbors etc.).
ClinicalTrials.gov, NCT04899830

Sites

  • CR MulhouseMulhouse, Alsace, France
  • IUR ClémenceauStrasbourg, Alsace, France
  • CMRRF de KerpapePloemeur, Brittany Region, France
  • CMPR Côte d'AmourSaint-Nazaire, Pays de la Loire Region, France